Bionano Genomics, Inc. (BNGO) › Cost of RevenueBionano Genomics, Inc. (BNGO) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2017: $6.03M2018: $8.71M2019: $6.77M2020: $5.73M2021: $14.11M2022: $21.86M2023: $26.55M2024: $30.40M2025: $15.32M$15.32M2017Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$15.32M-49.6%2024$30.40M+14.5%2023$26.55M+21.5%2022$21.86M+54.9%2021$14.11M+146.2%2020$5.73M-15.3%2019$6.77M-22.3%2018$8.71M+44.5%2017$6.03M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share